Abstract Purpose The Contrast Media Safety Committee (CMSC) of the European Society of
Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced …

Radiocontrast media (RCM) are medical drugs used to improve the visibility of internal
organs and structures in X‐ray based imaging techniques. They may have side effects …

Statins or 3-hydroxy-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors not only
prevents the synthesis of cholesterol biosynthesis but also inhibits the synthesis of essential …

Objectives: This study was designed to investigate whether an acute atorvastatin reload
before percutaneous coronary intervention (PCI) protects patients receiving chronic statin …

Objectives: This study sought to evaluate the safety and efficacy of rosuvastatin in preventing
contrast-induced acute kidney injury (CI-AKI) in patients with diabetes mellitus (DM) and …

It is well known that iodinated radiographic contrast media may cause kidney dysfunction,
particularly in patients with preexisting renal impairment associated with diabetes. This …

Background—The role of statins in the prevention of contrast-induced acute kidney injury
(CIAKI) is controversial. Methods and Results—First, we investigated the in vivo effects of …

Contrast-induced nephropathy (CIN) impairs clinical outcome in patients undergoing
angiographic procedures. The aim of this study was to investigate whether short-term high …

Abstract The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, better known as
'statins', are amongst the most widely used medications in the world. They have become a …

We investigated the efficacy of short-term high-dose atorvastatin in decreasing the risk of
contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) subjected …